focusing on the future of tech and life science in north carolina

 MARCH 17-19, 2020 | Raleigh Convention Center

Redefining the traditional conference, Venture Connect, is a new three-day experience. Recognizing the innovation potential across the Tech & Life Science communities, we are focused on creating an environment that supports stronger connections, valuable programming, and learning for all.

Get Tickets


what you can expect

This powerhouse event is clear evidence of how strong our tech and life sciences ecosystems really are.

125

Entrepreneurial Companies Onstage

200+

Regional and Out-of-State Investors Onsite

1400+

Summit Attendees

500+

1:1 Meetings

EARLY
Nov 11 – Feb 14
REGULAR
Feb 15 – Mar 11
ON-SITE
Mar 17 – 19
ENTREPRENEURIAL COMPANIES
$350
$500
$650
GENERAL ADMISSION
$650
$950
$1250

visit the full Summit Agenda and download the app, viewable either on desktop or mobile. Gain access to features like:

partnering (meetings) | agenda planning | presenting company and speaker information| ancillary events| summit maps and more!

THE SHERATON

421 South Salisbury Street, Raleigh, NC 27601
Rate: $169 plus taxes
Cut off date: Feb. 24 at 5pm Eastern Time
Reservations: 800-325-3535
Ask for CED Conference rate

Book Here

RESIDENCE INN RALEIGH DOWNTOWN

616 South Salisbury Street, Raleigh, NC 27601
$189 plus taxes, includes full breakfast
Cutoff date: March 4 at 5pm Reservations: 919-856-0017 reference group code VCS

Book Here

Who Attends?

The Summit attendees are ones that are: Scaling start-ups and growth stage companies, Local and out-of-state investors looking to connect, NC Corporate and strategic partners, Community resources aligned with the growth of companies, Explorers looking to connect with others.

Where will Venture Connect be Held?

The Summit attendees are ones that are: Scaling start-ups and growth stage companies, Local and out-of-state investors looking to connect, NC Corporate and strategic partners, Community resources aligned with the growth of companies, Explorers looking to connect with others.

Are there an sponsorship opportunities available?

Yes, sponsorship packages are available in a wide range of options. A sponsorship can provide your company with high-profile visibility to a large number of influential executives and decision-makers in attendance. See our sponsorship package for details.

What is the closest airpoort?

(RDU) is the nearest airport to the Raleigh Convention Center.

Am I allowed to record any portion of the Summit?

No, any unauthorized recording of the Summit sessions or events is strictly prohibited.

Will anyone be taking pictures at the Summit?

Yes, pictures will be taken during the Summit. By registering for the Summit, you acknowledge that there is a possibility your picture may be taken.


summit leaders

The summit is a collaborative effort that brings together the ecosystem, as well as out-of-region supporters interested in entrepreneurial activity in North Carolina.  Sort highlighted speakers and summit chairs by selecting a category below.

bill hawkins

Summit Leader

Bill Hawkins

Former Chairman and CEO of Medtronic

Mr. Hawkins is retired Chairman and CEO of Medtronic and currently a corporate director serving on public and private boards as well as non for profit boards. He was recently elected to the National Academy of Engineering and is an AIMBE Fellow.

Mr. Hawkins currently serves as Lead Director and previously served as President and CEO of Immucor (a private equity backed company) from October 2011 to July 2015.  Prior to Immucor, Mr. Hawkins served as Chairman and CEO of Medtronic, one of the worlds’ largest and most innovative medical technology companies. Mr. Hawkins assumed the role of CEO in 2007 and became Chairman of the Board in 2008. He joined Medtronic in 2002 as SVP and President of Medtronic Vascular. He served in that role until June 2004. From 2004 until August 2007 he was President and Chief Operating Officer of Medtronic.

Prior to Medtronic, Mr. Hawkins served as President and Chief Executive Officer of Novoste Corp. Nasdaq (NOVT) and held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977. 

Mr. Hawkins received his bachelor’s degree in electrical and biomedical engineering from Duke in 1976, where he also conducted medical research in pathology. He then went on to earn an M.B.A. from the Darden School of Business, University of Virginia, in 1982.

He is a Senior Advisor to EW Healthcare Partners, a leading private equity firm investing in life sciences. Mr. Hawkins serves as a Director of Avanos Health NYSE: AVNS. He is Chairman of the Board of Bioventus, and 4Tech; a cardiology startup in Ireland, and on the Board of Virtue Labs, Baebies, Cereius, AskBio, Cirtec Medical, Biogen (BIIB: NASDAQ) and Tissue Tech.  Mr. Hawkins is the past Chairman and Co-Founder of the Medical Device Innovation Consortium (“MDIC”) and past-president of the American Institute of Medical and Biological Engineering (“AMIBE”).  Mr. Hawkins was elected to the Duke University Board of Trustees in 2011 and currently serves as Vice Chairman of the Board. He is on the Executive Committee and the Audit, Risk and Compliance Committee.  Mr. Hawkins is Chair of the Board of the Duke University Health System.  He is a member of the NC Biotech board and serves on the Board of the Focused Ultrasound Foundation Society.

Mr. Hawkins also serves as a Member of the Advisory Boards at Arboretum Ventures, Hatteras Venture Partners, HealthQuest Ventures, and past member of A*STAR SERC Cluster Advisory Board in Singapore, and the Biomedical Research Council of Singapore.”

Summit Leader

Steve Nelson

Co-Founder at Carbon, Inc.

Steve served as Carbon’s launch CEO. After raising the original Series A funding from Sequoia Capital, he became the initial Chairman of the company.

Steve is also Co-founder of re—inc, a purpose-driven, global lifestyle and wellness company founded by 2019 World Cup Champions, Megan Rapinoe, Tobin Heath, Christen Press, and Meghan Klingenberg. Additionally, he is an advisor to Chopra Global and its not-for-profit partner, The Chopra Institute, with world-renowned pioneer in integrative medicine, Dr. Deepak Chopra, MD. Steve is also lead investor in and board member of Diveplane Corporation, a technology company dedicated to keeping the humanity in AI.

Steve has served on the boards of many companies, including Blue Cross of North Carolina since 2002 until today, where he recently concluded a four-year term as Chairman. Steve was also Managing Partner at venture capital firm, Wakefield Group, for 14 years. He joined Wakefield after 19 years of executive and general management experience in technology, software, business services, and cloud computing businesses, including at Quokka Sports and NBC/Quokka Ventures. He was formerly VP of the Americas for Informix Software in Menlo Park, CA. His business career began at IBM, where he served for 14 years in Chicago and White Plains, NY, and then ultimately as VP and General Manager in San Francisco.

Steve received his B.S. degree in Business from Wake Forest University. He is a former member of the Board of Trustees at Wake Forest, the Board of Visitors at Duke University’s Fuqua School of Business, and was Foundation Board Chair at the North Carolina School of Science and Mathematics.


melissa smith

Summit Leader

Melissa Smith

Managing Director, Head of Specialized Industries, Middle Market Banking, J.P. Morgan

Melissa Smith is the Head of Specialized Industries for JPMorgan’s Middle Market Banking & Specialized Industries (MMBSI) business. She leads a team of national managers responsible for industry verticals including Agribusiness, Apparel, Beverage, Emerging Growth, Life Sciences, Media and Entertainment, Technology, and the Middle Market Financial Sponsors Group. The industry teams provide traditional banking services and investment banking solutions to mid-cap sized companies across the country.Melissa is also responsible for the Government, Healthcare, Higher Ed, and Not-for-Profit businesses within MMBSI and sits on the Management Committee for the Commercial Bank.

Prior to joining MMBSI, Melissa spent 3 years as the Northeast Group Head for Corporate Client Banking & Specialized Industries (CCBSI) where she also served on the Management Committee. Since joining CCBSI she has acted as the Regional Chair for the Northeast Market Leadership Teams and as Senior Sponsor for the CB Columbia recruiting team.

Melissa joined the firm in 1998 in Public Finance and has spent most of her career in the Corporate & Investment Bank (CIB), most recently as the Head of EMEA Investment Grade Finance in London. As part of her role running the DCM business in Europe, Melissa was a co-chair of the Debt Underwriting Commitments Committee (DUCC), a member of the EMEA balance Sheet Committee, a senior sponsor of the ED Connect program in EMEA and a member of the Analyst and Associate Development Council.Prior to her London move, she spent 14 years in the Debt Capital Markets group in New York as the Head of the Consumer, Retail, Healthcare and Chemicals team.

Melissa received a BA in Political Science from American University and a Masters in Public Policy from the University of Chicago. Since 2009, she has served on the Board of Trustees of American Ballet Theatre.

Summit Leader

Mike Capps

Founder/CEO Diveplane Corporation

Dr. Michael Capps is a well-known technologist and CEO of Diveplane Corporation, which develops transformative technology that keeps the humanity in AI. Before co-founding Diveplane, Mike had a legendary career in the videogame industry as president of Epic Games, makers of blockbusters Fortnite and Gears of War. His tenure included a hundred game-of-the-year awards, dozens of conference keynotes, a lifetime achievement award, and a successful free-speech defense of videogames in the U.S. Supreme Court. He’s survived trending on Twitter, iPhone launch events with Steve Jobs, and raising two toddlers. Michael began his career with post-graduate degrees at UNC, MIT, and the Naval Postgraduate School; for his research in VR, he was one of 50 scientists featured in SIGGRAPH’s historical documentary on computer graphics. He has keynoted dozens of conferences, and remains a regular host of television series on the Discovery and Science Channels.  

Summit Leader

Sheila Mikhail

CEO, President, Co-Founder AskBio

Sheila Mikhail co-founded and was the initial CEO of AskBio from 2002 through 2007. Ms. Mikhail left the company to become CEO of NanoCor Therapeutics, Inc. Most recently, Ms. Mikhail co-founded and was CEO of Bamboo Therapeutics, Inc., which in 20 months raised $50 million, advanced a therapeutic for GAN into the clinic, completed Pre-IND studies for the Duchenne Muscular Dystrophy therapeutic, and built a GMP manufacturing facility. Bamboo was acquired by Pfizer in August 2016.

Trained as a lawyer, Ms. Mikhail practiced law for over 15 years, including a law firm that she founded, Life Sciences Law, which serviced clients such as Bayer, Gilead, GSK, Sanofi, and Aventis. Ms. Mikhail also practiced with Ropes and Gray in Boston. Ms. Mikhail earned a JD, with honors, from Northwestern University; a finance MBA, with honors, from the University of Chicago; and a BS, with highest honors, from the University of Illinois at Urbana-Champaign.


summit speakers

explore the profiles of our speakers and panelists. The Summit is loaded with some of the nation’s top talent in the tech and life science industries. We are always adding more speakers, so keep checking back!

view the full speaker list now

physicist and a biotech entrepreneur

Safi Bahcall

Safi is a second-generation physicist (the son of two astrophysicists), a biotech entrepreneur, and former public-company CEO.

He received his BA summa cum laude from Harvard and his PhD in physics from Stanford, where he worked with Lenny Susskind in particle physics (the science of the small) and the Nobel laureate Bob Laughlin in condensed matter physics (the science of the many). He was a Miller Fellow in physics at UC Berkeley (the school of the many). After working for three years as a consultant for McKinsey, Safi co-founded a biotechnology company developing new drugs for cancer. He led its IPO and served as its CEO for 13 years.

In 2008, he was named E&Y New England Biotechnology Entrepreneur of the Year. In 2011, he worked with President Obama’s council of science advisors (PCAST) on the future of national research.

Safi regularly speaks with leadership teams about applying the ideas in Loonshots (more here) and has presented at industry conferences, investor events, medical meetings, and leading academic institutions around the world.

Loonshots, Safi’s first book, has been translated into 18 languages; recommended by Bill Gates, Daniel Kahneman, Daniel Pink, Adam Grant, Malcolm Gladwell, and Tim Ferriss; and selected as a best business book of the year by Amazon, Bloomberg, Business Insider, Financial Times, Forbes, Inc., Medium, Strategy + Business, Tech Crunch, and the Washington Post. It was the most recommended book of the year in Bloomberg’s annual survey of CEOs and entrepreneurs.

Safi lives with his wife, two children in Cambridge, MA.

Chairman of the Board, Chief Executive Officer Amicus Therapeutics, Inc

John Crowley

John Francis Crowley is the Chairman and CEO of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. John has been Amicus CEO since 2005 and has overseen the company’s growth from a four person start-up to one with operations in more than 30 countries, with 550+ employees and a market value of nearly $3 Billion. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children’s lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics. 

John and his family have been profiled on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, “The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children.” The major motion picture, Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family journey. John is the author of a personal memoir: Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. 

John served as a commissioned intelligence officer in the U.S. Navy Reserve from 2005-2016, assigned to the United States Special Operations Command and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University, and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard. The Crowley family was the recipient of the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science & Technology at Notre Dame. John served as the National Chairman of the Make-A-Wish Foundation of America (2014-2016) and is a founding Board member of the Global Genes Project. John is a Henry Crown Fellow at the Aspen Institute.

Board Member, EyePoint Pharmaceuticals

Wendy DiCicco

Wendy DiCicco is an experienced C-suite executive and a corporate director with an array of corporate leadership accomplishments for both public and private companies. She currently serves on the boards of EyePoint Pharmaceuticals (NASDAQ: EYPT), where she serves as the Audit Committee Chair, and Carmell Therapeutics.  She has previously served on three additional public and private corporate boards, including boards in the medical device, semiconductor and biotechnology sectors, where she has experience chairing the audit, compensation and governance committees.  Ms. DiCicco is also a Financial, Executive and Board Advisory Consultant for several emerging growth companies.  At the C-level, she brings broad, practical leadership experience including financial and operational acumen as a CFO, COO and President. Most recently, Ms. DiCicco was the Chief Operating and Chief Financial Officer of Centinel Spine and previously the President and Chief Operating Officer at Camber Spine Technologies. Prior to these two privately held spinal technology companies, Ms. DiCicco served as the Chief Financial Officer for several private and public medical device and biotechnology companies, including Kensey Nash Corporation (NASDAQ:KNSY), where she served as CFO for 12 years. Ms. DiCicco started her career with Deloitte & Touche in audit assurance.  Ms. DiCicco also serves in the community, where she is currently on the board of the Chester County Library System and the Philadelphia Chapter of the National Association of Corporate Directors (NACD). She is a Corporate Governance Fellow as well as a Board Leadership Fellow of the NACD. Ms. DiCicco graduated from Philadelphia College of Textiles and Science with a B.S. degree in Accounting and is a CPA in the state of Pennsylvania.  

Community Evangelist at AvidXchange

Chris Elmore

Chris was a millionaire at age 28… For six weeks. The first tech company he started fell like a lead
balloon. He dusted himself off and would soon be one of the earliest employees of a tech company that went from $0.00 in revenue and three product failures to thousands of employees and business unicorn status. His out of the box approach of putting people first and concentrating on selling value has helped thousands.

Called a “Startup Hero” by North Carolina Business Magazine and a maverick and mold breaker by SouthPark Magazine, Chris has written 9 books, and is a Professor of Entrepreneurship and Innovation at UNC – Charlotte and Queens University of Charlotte. Chris serves on the board of four startups and advisor three other Charlotte-based companies. Chris travels the country speaking on the topics of startup success, innovation, entrepreneurship, sales, technology, and automation. Chris began working at AvidXchange in 2000 as one of its earliest employees. AvidXchange, a global unicorn, aka a private company valued at +$1 billion, is one of the fastest-growing fintech companies in the country with 1,300 employees across seven offices.

Chris has been on a journey to perfect a message that resonates and motivates audience since he wa18 years old. “My dad had me read the book, See You At The Top, by Zig Ziglar. I fell in love with the ideas and with making improvements in my life.” “The best testimonial I can give you to hire me to speak is my wife still loves me, loves being around me, and still thinks I am funny, and we have been together since 1992”. Chris lives in Lake Wylie SC, where teaching, business, four kids and a wife keep him very busy.

Chairman and Chief Executive Officer, Live Oak Bancshares

Chip Mahan

Chip Mahan is the founder, Chairman and CEO of Live Oak Bancshares. He serves on the board of directors for Apiture, a joint venture between Live Oak and First Data which focuses on creating next-gen technology for financial institutions. He is also a director of Payrailz, a digital payments company which offers advanced solutions for the financial services industry. Chip is a co-founder of nCino, a cloud-based banking software built on the Salesforce platform.

Prior to Live Oak, Chip was the Chairman and CEO for S1 Corporation and founder of Security First Network Bank, the world’s first Internet bank. Under his leadership, S1 Corporation grew to become a $234 million software and services provider in only six years, averaging more than 200 percent growth year over year. At its peak, S1 had a market capitalization of $7.8 billion. During his term as CEO, Chip was ranked as one of the 10 Most Influential Personalities in Financial Services by FutureBanker magazine.

Prior to founding Security First Network Bank and S1 Corporation, he launched Cardinal Bancshares, where he served as Chairman and CEO. Chip built Cardinal into an institution with $800 million in total assets and took the company public in 1992. Before launching Cardinal, Chip spent several years with Citizens Union National Bank & Trust Co., serving as President, Chief Operating Officer and Vice Chairman and becoming Chairman and CEO in 1984. In 1986, he formed an investment group that purchased Citizens Union and subsequently sold it to BankOne Corp. of Columbus, OH. Chip began his career in 1973 at Wachovia Bank & Trust Co. in Winston-Salem, NC, after graduating with a bachelor’s degree in economics from Washington & Lee University in Lexington, VA.

Chief Product Officer, Relias

Mike Mutka

Executive leader with 25+ years experience in medical equipment, products, and software. Drove growth of Silverchair Learning (SLS) from $78K of revenue at the start of 2005 to $15 million in 2011 with 25% EBITDA. Led process of selling SLS to Vista Equity Partners in May 2012, which (along with Essential Learning) became Relias Learning. Helped integrate EL and SLS into Relias Learning, building sales and marketing leadership team before starting our first Strategy and M&A team in late 2013. In September 2014, after just 2 years, Vista sold Relias to Bertelsmann, which became one of the most successful exits in Vista’s history. Have completed 13 highly successful acquisitions since May 2013. Led development of company growth strategy – Relias doubled revenue from 2012 to 2014, and tripled from 2014 to 2017 while growing from 130 employees in 2012 to nearly 700 today. During this time Relias has expanded across the healthcare continuum and globally while increasing our TAM from $600 million to over $4 billion. In 2017, was asked to form a new start-up company called Straightaway Health Careers.

Chairman of the Board of Directors, Biogen, Inc., Exelixis, Inc., and Regulus Therapeutics, Inc.

Dr. Stelios Papadopoulos

Dr. Stelios Papadopoulos is Chairman of the Board of Directors of Biogen, Inc., Exelixis, Inc., and Regulus Therapeutics, Inc.  He is a co-founder of Exelixis, Inc. as well as co-founder and former Chairman of Anadys Pharmaceuticals, Inc. (acquired by Hoffman – La Roche in 2011) and Cellzome, Inc. (acquired by GlaxoSmithKline in 2012).  In the not-for-profit sector, Dr. Papadopoulos is co-founder and Chairman of Fondation Santé (www.fondationsante.org), a member of the Board of Visitors of Duke Health, and a member of the Global Advisory Board of the Duke Institute for Health Innovation. 

Dr. Stelios Papadopoulos retired as Vice Chairman of Cowen & Co., LLC in 2006 after six years with the firm whereas an investment banker he focused on the biotech and pharma sectors. Prior to joining Cowen, he spent 13 years as an investment banker at PaineWebber, Incorporated where he was most recently Chairman of PaineWebber Development Corp., a PaineWebber subsidiary focusing on biotechnology. He joined PaineWebber in 1987 from Drexel Burnham Lambert where he was an analyst in the Equity Research Department covering the biotechnology industry. Prior to Drexel, he was the biotechnology analyst of Donaldson, Lufkin & Jenrette. For his work as an equity analyst he was elected in the Institutional Investor 1987 All America Research Team.  He has also received multiple honors and awards for his work in the biopharma industry as a company founder, advisor and financier. 

Before coming to Wall Street, Dr. Papadopoulos was on the faculty of the Department of Cell Biology at New York University School of Medicine.  Dr. Papadopoulos holds an M.S. in physics, a Ph.D. in biophysics and an M.B.A. in finance, all from New York University. 

CEO, Relias

Jim Triandiflou

Jim Triandiflou has been the CEO of Relias since 2012.  Under his leadership, Relias has grown from 100 to 800 employees.  This is Jim’s third time as a software company CEO. In 2017 Jim was named the North Carolina Triangle Business Person of the Year.  Jim is also Chairman of the Board of North Carolina Special Olympics and embraces Relias’ mission to improve the lives of the most vulnerable members of society.

Co-Founder, President and COO, Well

Dave Werry

David was previously the VP of Transformation at Aetna where he oversaw the member-facing capabilities for the enterprise. These areas included Aetna’s digital assets, concierge services, Apple partnership, high-touch clinical services as well as business units in healthcare payments, benefits enrollment and population health management.

Prior to joining Aetna, David was the Head of Biotech at PPD, a global clinical research organization. David began his career at Morgan Stanley and then Hellman & Friedman, a large private equity firm, where he focused on healthcare investing.

David was a Morehead Scholar at the University of North Carolina and holds an MBA from Harvard Business School.

Director, Strategic Content – NCDA

Kimberly Simpson

Kimberly Simpson is director of strategic content for the National Association of Corporate Directors (NACD), leading NACD’s credentialing programs (NACD Directorship Certification™ and NACD Fellowship®), co-leading the organization’s Fortune 500 advisory councils, and routinely contributing to NACD member education through blogs and articles. Formerly, Simpson was NACD’s first regional director. Prior to joining NACD, Simpson was executive vice president at Sanford Health and was the inaugural president of the Edith Sanford Breast Cancer Foundation. She was chief operating officer and general counsel for Susan G. Komen for the Cure and served as secretary to the board of directors. Simpson also was a director of the Susan G. Komen for the Cure Advocacy Alliance, Komen’s Washington, DC-based policy organization. Earlier, Simpson was vice president and general counsel at Texas Scottish Rite Hospital for Children. She was a US Marshall Memorial Fellow to Europe in 2005

Get Tickets


presenting companies

Check out all of the amazing tech and life science companies that will be presenting on stage at Venture Connect!

view the full company list now

6am city

6am City

Achelios Thera

Achelios Therapeutics

Advanced Chemo

Advanced Chemotherapy Technologies

Advanced Nano

Advanced Nanocoatings Incorporated

Adzerk

Adzerk

AgEye

AgEye Technologies

allstacks

Allstacks

Altis

Altis Biosystems, Inc.

AnelleO

AnelleO, Inc.

aniluxx

Aniluxx Biotechnology

UNRIVALED CONTENT

Nonstop programming and workshops over three days, packed full of both technology-rich and life science-focused content that will equip you with the knowledge you’re looking for to take your venture to the next level.

CALCULATED COLLISION

Be a part of the largest gathering of innovative tech and life science companies under one roof in this region.This powerhouse event showcases the strength of our growing ecosystem and you don’t want to miss out on the opportunities that await.  

 

HIGH-PROFILE SPEAKERS

A three-day agenda loaded with some of the nation’s top talent in the tech and life science industries on topics you want to explore. Past speakers have included: John Doerr, Jim Goetz, Clayton Christensen and John Carreyrou.

COMPANY
VISIBILITY

Venture Connect offers companies the unique opportunity to present their scaling plans to investors and potential partners over 3 days. Join along with over 125 national and local companies live on-stage as they present their company goals to gain visibility and potential backing.

LIFE DIGITIZED

Companies that integrate digital technology with the intent to streamline everyday life.

E-Commerce | Smart devices | Digital health

and more

BUSINESS OPTIMIZED

Companies that offer solutions to increase productivity and efficiency in business. 

Artificial Intelligence | Augmented Reality | Big Data | Cyber Security

and more

LIFE IMPROVED

Companies creating solutions that improve the quality of life and well being of the human race.

Therapeutics | Medical Devices | Advanced Diagnostics

and more

download our media kit and help us spread the word about Venture Connect!

Venture Connect Media Kit


headline sponsor

We are excited to announce J.P. Morgan as headline sponsor for the Summit. They have been a consistent supporter of CED for years and we value their involvement in enabling us to provide a powerful program.

J.P. Morgan Press Release


sponsor

A special thank you to all of our sponsors who have helped to bring you Venture Connect – 2020 Summit. You can view a highlight of our partners below. If you are interested in becoming a sponsor – we’d love to chat with you.

Download Sponsorship Package

Deloitte

Track Sponsor

Wilson Sonsini Goodrich & Rosati

Track Sponsor

NC Biotechnology Center

Partnering Sponsor

Hutchison PLLC

Tech Investor Dinner Sponsor

Pacific Western Bank

Tech Investor Dinner Sponsor

Smith Anderson

Life Science Investor Dinner Sponsor

Alexandria

Life Science Breakfast Sponsor

GlaxoSmithKline

Premium Featured Content Sponsor

RSM

Premium Featured Content Sponsor

Vaco

Premium Featured Content Sponsor

Wyrick Robbins

Premium Featured Content Sponsor

Cambrex

Featured Content Sponsor

Nuventra

Featured Content Sponsor

PWC

Featured Content Sponsor

Red Hat

Featured Content Sponsor

Alcami

Networking Sponsor

Bradley

Networking Sponsor

Cisco

Networking Sponsor

McGriff Insurance Services

Networking Sponsor

Mispro Biotech Services

Networking Sponsor

North Carolina Biosciences Organization (NCBIO)

Life Science

Pappas Capital

Networking Sponsor

Parexel

Networking Sponsor

Pfizer CentreOne

Networking Sponsor

Precision BioSciences

Networking Sponsor

Quality Back Office

Accounting Firms

Research Triangle Foundation

Networking Sponsor

Bashyam Shah

Reception Sponsor

EY

Reception Sponsor

Veracity Logic

Reception & Signature Drink Sponsor
Baering

Baering

PR Partner

Edge Office

Relax Sponsor

Ellie

Collaborator

GrepBeat

Media

Hypepotamus

Media Partner

StoryDriven

Story Partner

Studio TK

Relax Sponsor

UNC-TV

Production Partner

Zig Zibit

Experience Partner

Venture Connect Resources

Not finding the information you need about Venture Connect? Here are few more links that will help.

get the latest

X
X